Bristol-Myers Squibb to Take Part in Goldman Sachs 39th Annual Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Jun 11, 2018--Bristol-Myers Squibb Company (NYSE: BMY) will take part in Goldman Sachs 39 th Annual Global Healthcare Conference on Wednesday, June 13, 2018, in Rancho Palos Verdes, CA. Johanna Mercier, Head of U.S. Commercial, and Fouad Namouni, Head of Oncology Development, will answer questions about the company at 6:20 p.m. ET (3:20 p.m. PT).
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180611006205/en/
CONTACT: Bristol-Myers Squibb
Ken Dominski, 609-252-5251
Tim Power, 609-252-7509
Bill Szablewski, 609-252-5894
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL GENERAL HEALTH
SOURCE: Bristol-Myers Squibb Company
Copyright Business Wire 2018.
PUB: 06/11/2018 04:45 PM/DISC: 06/11/2018 04:45 PM